369 related articles for article (PubMed ID: 23597047)
1. Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.
Jacobson KA
J Med Chem; 2013 May; 56(10):3749-67. PubMed ID: 23597047
[TBL] [Abstract][Full Text] [Related]
2. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
[TBL] [Abstract][Full Text] [Related]
5. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
Zeng L; Guan M; Jin H; Liu Z; Zhang L
Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
[TBL] [Abstract][Full Text] [Related]
6. In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors.
Salmaso V; Jacobson KA
Biomolecules; 2020 May; 10(6):. PubMed ID: 32466404
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A2A receptor as a drug discovery target.
de Lera Ruiz M; Lim YH; Zheng J
J Med Chem; 2014 May; 57(9):3623-50. PubMed ID: 24164628
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches for targeting the adenosine A2A receptor.
Yuan G; Gedeon NG; Jankins TC; Jones GB
Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
[TBL] [Abstract][Full Text] [Related]
9. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
[TBL] [Abstract][Full Text] [Related]
10. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.
Ciancetta A; Jacobson KA
Methods Mol Biol; 2018; 1705():45-72. PubMed ID: 29188558
[TBL] [Abstract][Full Text] [Related]
11. Probing GPCR structure: adenosine and P2Y nucleotide receptors.
Jacobson KA; Costanzi S; Deflorian F
Methods Enzymol; 2013; 520():199-217. PubMed ID: 23332701
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.
Al-Attraqchi OHA; Attimarad M; Venugopala KN; Nair A; Al-Attraqchi NHA
Curr Pharm Des; 2019; 25(25):2716-2740. PubMed ID: 31333093
[TBL] [Abstract][Full Text] [Related]
13. Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A
Lu Y; Liu H; Yang D; Zhong L; Xin Y; Zhao S; Wang MW; Zhou Q; Shui W
ACS Chem Biol; 2021 Jun; 16(6):991-1002. PubMed ID: 34048655
[TBL] [Abstract][Full Text] [Related]
14. John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.
Jacobson KA; Gao ZG; Paoletta S; Kiselev E; Chakraborty S; Jayasekara PS; Balasubramanian R; Tosh DK
Comput Struct Biotechnol J; 2015; 13():286-98. PubMed ID: 25973142
[TBL] [Abstract][Full Text] [Related]
15. Docking Finds GPCR Ligands in Dark Chemical Matter.
Ballante F; Rudling A; Zeifman A; Luttens A; Vo DD; Irwin JJ; Kihlberg J; Brea J; Loza MI; Carlsson J
J Med Chem; 2020 Jan; 63(2):613-620. PubMed ID: 31846328
[TBL] [Abstract][Full Text] [Related]
16. Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).
Jacobson KA
Bioconjug Chem; 2009 Oct; 20(10):1816-35. PubMed ID: 19405524
[TBL] [Abstract][Full Text] [Related]
17. Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A
Comeo E; Kindon ND; Soave M; Stoddart LA; Kilpatrick LE; Scammells PJ; Hill SJ; Kellam B
J Med Chem; 2020 Mar; 63(5):2656-2672. PubMed ID: 31887252
[TBL] [Abstract][Full Text] [Related]
18. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in the In-silico Structure-based and Ligand-based Approaches for the Design and Discovery of Agonists and Antagonists of A2A Adenosine Receptor.
Agrawal N; Chandrasekaran B; Al-Aboudi A
Curr Pharm Des; 2019; 25(7):774-782. PubMed ID: 30848185
[TBL] [Abstract][Full Text] [Related]
20. Structure-based discovery of A2A adenosine receptor ligands.
Carlsson J; Yoo L; Gao ZG; Irwin JJ; Shoichet BK; Jacobson KA
J Med Chem; 2010 May; 53(9):3748-55. PubMed ID: 20405927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
